Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation

European Journal of Clinical Investigation

Volumn 30, Issue 10, 2000, Pages 861-865

  Crook, M A ^a   Scott, D A ^a   Stapleton, J A ^a   Palmer, R M ^a   Wilson, R F ^a   Sutherland, G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

C reactive protein; Cotinine; Human; Inflammatory diseases; Sialic acid; Smoking

Indexed keywords

C REACTIVE PROTEIN; CARBON MONOXIDE; COTININE; SIALIC ACID;

ADULT; ARTERY DISEASE; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPIRED AIR; FEMALE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; TOBACCO;

ADULT; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 0033792459     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00738.x     Document Type: Article

References (45)

1. Production of C-reactive protein and risk of coronary events in stable and unstable angina
2. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
3. C-Reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
4. Prospective study of C-Reactive protein and the risk of future cardiovascular events in apparently healthy women
5. Plasma concentration of C-Reactive protein and the risk of developing peripheral vascular disease
6. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
7. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy
8. Sialic acid and cardiovascular mortality
9. Serum total sialic acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationship to acute phase proteins
10. Serum sialic acid concentration and smoking: A population based study
11. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: Multi variate analysis including 54385 men and women during 20·5 years follow up
12. Perchlorosoluble glycoproteins and myocardial infarct: Modifications of the carbohydrate moiety
13. Serum sialic acid and its relevance to diabetes mellitus
14. Occurrence of sialic acids in healthy humans and different disorders
15. Involvement of the haemostatic system in insulin resistance syndrome: A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group
16. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease
17. Properties of acute phase proteins of human plasma
18. Variations of plasma sialic acid and N-acetylglucosamine levels in cancer, inflammatory diseases and bone marrow transplantation: A NMR spectroscopy study
19. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction
20. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers
21. A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants
22. Serum sialic acid as an indicator of change in coronary artery disease
23. C-reactive protein in population samples
24. Cigarette smoking influences cytokine production and antioxidant defense
25. Lifetime smoking exposure affects the association of C-Reactive protein with cardiovascular risk factors and subclinical disease in healthy elderly subjects
26. Comparison of tests used to distinguish smokers from non-smokers
27. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers
28. Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial
29. A modified procedure for determination of nicotine in blood
30. The determination of serum or plasma sialic acid
31. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
32. Association of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease
33. IFNB2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes
34. NIDDM is a disease of the innate immune system: Association of acute phase reactants and interleukin-6 with metabolic syndrome X
35. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound
36. The acute phase reaction and hematological stress in vascular disease
37. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions
38. On the pathogenesis of atherosclerosis: Enzymatic transformation of human low-density lipoprotein to atherosclerotic moiety
39. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis
40. Von Willebrand antigen and dental infections
41. Metabolic and scintigraphic studies of radioionated human C-reactive protein in health and disease
42. Plasma leukocyte elastase concentrations in smokers
43. Effect of cigarette smoking on plasma metalloproteinase-9 concentration
44. Serum IgE in nonatopic smokers, nonsmokers, and recent exsmokers: Relation to lung function, airway symptoms, and atopic predisposition
45. Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smoking